Al-Khudairi explains how the world's first drug treats cancer

Citizen – Riyadh

The new drug, Vitrakavi, is the genetic origin of cancer and treats the origin of the tumor and mutant genes before the tumor spreads, said Dr. Fahd al-Khudairi, a researcher in the field of carcinogenicity.

He pointed out that it is the first drug meeting these specifications and that it will change 100% treatment methods.

"It's dedicated to tumors through an NTRK gene gene, not all tumors, and its price is $ 400,000." I'm optimistic about the possibility of reaching this stage of the options These discoveries will be followed by others for optimal treatment and will open the door to further discoveries and subsequent research – not the cell. "

The United States Food and Drug Administration (FDA) on Thursday approved the world's first drug that can treat cancer, from its source originally, to adults and children, treating genetic mutations of tumors cancerous, regardless of the type of disease or the place. His creation.

"Certification of the release and introduction of this drug is an important step in the treatment of cancer because it treats it from its source and treats the gene base of cancerous tumors regardless of the location of their origin in the human body, "said Commissioner Scott Gottlieb.

Gottlieb has confirmed that this new drug will help cancer patients get the right treatment. Vitracave helps treat people with different cancers, but their genetic mutations are common.